SitagliptinDPP-4 Inhibitor (Antidiabetic Preparations) Indication: Management of type 2 diabetes mellitus. Dosage & Administration: The recommended dose of Siglita™ is 100 mg once daily. Siglita™ can be taken with or without food.For patients with mild renal insufficiency (creatinine clearance [CrCl] 50 mL/min) no dosage adjustment for Siglita™ is required.For patients with moderate renal insufficiency (CrCl 30 to <50 […]